NTRK1 and glioblastoma: Genomic and transcriptomic analysis have identified the deregulation of TP53, RB1, and receptor tyrosine kinases (RTK)/Ras/PI3K pathway as very highly frequent, and have pointed to these signaling as a core requirement for GBM pathogenesis [3].